Loading...
Genetically Engineered Multivalent Proteins for Targeted Immunotherapy
Monoclonal antibodies initiated the unprecedented breakthroughs in cancer immunotherapy and are rapidly evolving with multiple therapeutic platforms. One next generation strategy engineers multivalent proteins that ligate single-chain variable fragments targeting cellular effectors, tumor-associated...
Na minha lista:
| Udgivet i: | Clin Cancer Res |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4947414/ https://ncbi.nlm.nih.gov/pubmed/27009744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0246 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|